Treatment of Danhong Injection with Atorvastatin on Endothelial Function and Inflammation Factors in Patients with Acute Coronary Syndrome After Percutaneous Coronary Intervention
|更新时间:2024-01-04
|
Treatment of Danhong Injection with Atorvastatin on Endothelial Function and Inflammation Factors in Patients with Acute Coronary Syndrome After Percutaneous Coronary Intervention
Chinese Journal of Experimental Traditional Medical FormulaeVol. 21, Issue 12, Pages: 154-157(2015)
GUO Jian-feng, WU Sheng-ben, YANG Jin-ping, et al. Treatment of Danhong Injection with Atorvastatin on Endothelial Function and Inflammation Factors in Patients with Acute Coronary Syndrome After Percutaneous Coronary Intervention[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(12): 154-157.
DOI:
GUO Jian-feng, WU Sheng-ben, YANG Jin-ping, et al. Treatment of Danhong Injection with Atorvastatin on Endothelial Function and Inflammation Factors in Patients with Acute Coronary Syndrome After Percutaneous Coronary Intervention[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(12): 154-157. DOI: 10.13422/j.cnki.syfjx.2015120154.
Treatment of Danhong Injection with Atorvastatin on Endothelial Function and Inflammation Factors in Patients with Acute Coronary Syndrome After Percutaneous Coronary Intervention
Objective: The purpose of this study was to investigate the clinical effect of Danhong injection with atorvastatin on endothelial function and inflammation factors in patients with acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI) surgery
and provide clinical basis for ACS therapy. Method: From 2012/5 to 2014/5
we collected 125 ACS cases treated with PCI in our hospital and divided them into 2 groups randomly
with 62 cases in control group and 63 cases in observation group. Besides conventional treatment
the control group was treated with atorvastatin and the observation group was treated with danhong injection combined with atorvastatin. Before and after treatment
the indexes of endothelial function including endothelin-1 (ET-1)
nitrogen monoxide (NO)
von willebrand factor (vWF) and flow-mediated dilation (FMD)
inflammation factors including tumor necrosis factor-α (TNF-α)
interleukin-1 (IL-1) and C reactive protein (CRP)
as well as complications were observed and compared. Result: Compared with those before treatment
the indexes of endothelial function including ET-1
NO
vWF and FMD were all improved after treatment. However
these indexes decreased more significantly in the observation group than in the control group
and all differences were statistically significant (P<0.05). The inflammation factors including TNF-α
IL-1 and CRP were all decreased after treatment in both groups. However
those decreased more significantly in the observation group than in the control group
with all differences statistically significant (P<0.05). Complications in the observation group was significantly lower than in the control group(7.9% VS 32.3%
P<0.05). Conclusion: Combination treatment of danhong injection and atorvastatin for ACS therapy can improve endothelial function and decrease inflammation factors and is worthy of study and further application in clinical treatment.
Effects of Danhong Injection on Protect Myocardium of Acute Coronary Syndrome Patients after Selective Percutaneous Coronary Artery Intervention
Efficacy-driving Mechanism of Danhong Injection for Stable Angina Pectoris Based on Composition-activity Relationship of Target Modules
Class-imbalance Prediction and High-dimensional Risk Factor Identification of Adverse Reactions of Traditional Chinese Medicine with Centralized Monitoring in Real-world Hospitals
Establishment and Evaluation of Rat Model of Acute Coronary Syndrome with Combined Blood Stasis and Poison
Research Progress on Pharmacological Mechanism of Danhong Injection in Treatment of Cardiovascular and Cerebrovascular Diseases
Related Author
ZHANG Yong-xiang
ZHANG Qiang
ZONG Wenjing
LIU Jun
YANG Wei
NIU Qikai
ZHANG Siqi
WANG Jing'ai
Related Institution
Institute of Basic Theory for Chinese Medicine,China Academy of Chinese Medical Sciences
Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences
College of Art and Science,Boston University
College of Public Health and Health Professions,University of Florida